Bio-Rad Laboratories
(BIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 406,913 | 433,280 | 403,800 | 457,850 | 390,001 |
| Marketable Securities | 1,214,753 | 1,217,954 | 1,208,900 | 1,306,703 | 1,338,245 |
| Receivables | 445,506 | 444,809 | 489,000 | 457,402 | 491,575 |
| Inventories | 803,693 | 783,369 | 780,500 | 775,818 | 776,600 |
| Other current assets | 32,376 | 38,782 | 26,100 | 25,087 | 19,804 |
| TOTAL | $3,056,254 | $3,060,936 | $3,048,300 | $3,146,770 | $3,138,866 |
| Non-Current Assets | |||||
| PPE Net | 533,767 | 522,364 | 529,000 | 511,389 | 514,013 |
| Investments And Advances | 5,099,554 | 8,018,383 | 7,698,100 | 7,218,161 | 7,311,135 |
| Intangibles | 719,209 | 726,419 | 734,100 | 721,140 | 740,229 |
| Other Non-Current Assets | 279,662 | 281,791 | 289,600 | 298,483 | 273,986 |
| TOTAL | $6,632,192 | $9,548,957 | $9,250,800 | $8,749,173 | $8,839,363 |
| Total Assets | $9,688,446 | $12,609,890 | $12,299,100 | $11,895,940 | $11,978,230 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 483 | 487 | 500 | 476 | 476 |
| Accounts payable and accrued liabilities | 126,693 | 102,750 | 144,600 | 111,859 | 149,535 |
| Accrued Expenses | 132,460 | 146,491 | 139,900 | 154,946 | 154,704 |
| Other current liabilities | 149,916 | 142,427 | 161,600 | 147,801 | 166,243 |
| TOTAL | $486,961 | $466,154 | $522,800 | $558,176 | $581,982 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,199,724 | 1,199,381 | 1,199,100 | 1,198,713 | 1,198,384 |
| Other Non-Current Liabilities | 344,512 | 352,232 | 360,500 | 353,300 | 349,143 |
| TOTAL | $2,422,698 | $3,092,605 | $3,035,100 | $2,921,569 | $2,949,354 |
| Total Liabilities | $2,909,659 | $3,558,759 | $3,557,900 | $3,479,745 | $3,531,336 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 27,871 | 28,525 | 28,518 | 29,145 | 29,076 |
| Common Shares | 3 | 3 | N/A | 3 | 3 |
| Retained earnings | 7,479,059 | 9,644,545 | 9,260,600 | 8,910,921 | 8,804,664 |
| Other shareholders' equity | -451,004 | -426,041 | -335,500 | -497,181 | -372,646 |
| TOTAL | $6,778,787 | $9,051,134 | $8,741,200 | $8,416,198 | $8,446,893 |
| Total Liabilities And Equity | $9,688,446 | $12,609,893 | $12,299,100 | $11,895,943 | $11,978,229 |